Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder

This 2007 randomized controlled trial evaluated the effects of transdermal testosterone therapy in postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD). The study found that testosterone therapy significantly improved sexual desire and activity levels compared to placebo, with increases in satisfying sexual episodes and overall sexual function scores. Testosterone